These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 21523472)
1. The subcutaneous defibrillator will replace the transvenous defibrillator. Crozier I J Interv Card Electrophysiol; 2011 Oct; 32(1):73-7. PubMed ID: 21523472 [No Abstract] [Full Text] [Related]
2. Who should receive the subcutaneous implanted defibrillator?: The subcutaneous implantable cardioverter defibrillator (ICD) should be considered in all ICD patients who do not require pacing. Poole JE; Gold MR Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1236-44; discussion 1244-5. PubMed ID: 24347599 [No Abstract] [Full Text] [Related]
11. Who should receive the subcutaneous implanted defibrillator?: Timing is not right to replace the transvenous implantable cardioverter defibrillator. Rav Acha M; Milan D Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1246-51; discussion 1251. PubMed ID: 24347600 [No Abstract] [Full Text] [Related]
12. Abdominal submuscular implant of subcutaneous implantable cardioverter-defibrillator in a young child. Kwok SY; Yam N; Lun KS; Chen RH; Au TW; Yung TC Europace; 2018 Sep; 20(FI2):f248. PubMed ID: 29401320 [No Abstract] [Full Text] [Related]
13. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator. Sinha SK; Mehta D; Gomes JA Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255 [TBL] [Abstract][Full Text] [Related]
14. A right-sided subcutaneous implantable cardioverter defibrillator in a patient with congenital heart disease. Waller JR; Salmon AP; Roberts PR Europace; 2015 Jan; 17(1):77. PubMed ID: 25414482 [No Abstract] [Full Text] [Related]
15. Post-shock oversensing by a subcutaneous defibrillator resulting in inappropriate withholding of post-shock bradycardia pacing. Maass AH; Van Gelder IC Europace; 2014 Jul; 16(7):1032. PubMed ID: 24792457 [No Abstract] [Full Text] [Related]